Generics 19

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Cycloserine manufacturers

19 products found

Filters

19 products found

cycloserine

Capsules 250 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #320
A pharmaceutical manufacturer based in the EU that has been active in 30+ countries selling its products in Europe, Africa, CIS, Middle East, and Asia for 50+ years. Key production lines are Rx, medical devices, cosmetics, and nutraceuticals. Main therapeutic areas include the cardiovascular system, CNS, and dermatology. Main dosage forms include oral liquids, semi-solid, and sterile injectables dosage forms. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 9 days

cycloserine

Capsules 250 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Serbia , Vietnam
Comments
Reference product: Seromycin, Elly Lilly
Manufacturer #3436

A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products in Europe, the Middle East, LATAM, North America, Africa, and Asia for 60+ years. Key production lines are Rx, OTC, and nutraceuticals. The company's production lines are EU GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and dermatology. Main dosage forms include solid, topical, and suppositories.

Manufacturer usually replies in 20 days

cycloserine

Capsules 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
PICS
Manufacturer #21567

Manufacturer usually replies in 2 days

cycloserine

Capsules 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Taiwan
GMP approvals
PICS
Manufacturer #21264
It was established in the 1970s. To uphold a mission of human health improvement, the company focuses on people's needs, assembling experts in the medical area, and being devoted to the research and development of high-barrier generic drugs and healthcare products. All of the health/medical products are broadly used in various medical institutions. After 40 years of striving for constant technique improvement. The company has become one of the most trustworthy partners.

Manufacturer usually replies in 1 days

cycloserine

Capsules 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
Sri Lanka, Afghanistan, Vietnam, Cambodia, Myanmar
Manufacturer #21102

Manufacturer usually replies in 5 days

cycloserine

Capsules 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19722

Manufacturer usually replies in 3 days

cycloserine

Tablets 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19722

Manufacturer usually replies in 3 days

cycloserine

Capsules 250mg; pack size: 30, 60

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
PICS
Manufacturer #9289
A pharmaceutical manufacturer based in Europe that has been active in 30+ countries selling its products in Europe, the Middle East, Africa, CIS, and Asia for 30+ years. The main therapeutic areas include gynecology, cardiology, urology, and antiviral. Key production lines are Rx Main dosage forms include solids, liquids, and injectables. The company's production lines are GMP-compliant.

Manufacturer usually replies in 4 days

cycloserine

Capsules 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

cycloserine

Tablets 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17417

Manufacturer usually replies in 6 days

cycloserine

Capsules 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17147

Manufacturer usually replies in 7 days

cycloserine + zinc

Capsules 250 mg + 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21424

Manufacturer usually replies in 13 days

cycloserine

Capsules 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21424

Manufacturer usually replies in 13 days

cycloserine

Tablets 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20158

Manufacturer usually replies in 11 days

cycloserine

Capsules 250 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19820

Manufacturer usually replies in 11 days

cycloserine

Tablets 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
India
Manufacturer #20740

Manufacturer usually replies in 19 days

cycloserine

Tablets 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20499

Manufacturer usually replies in 75 days

cycloserine + pyridoxine

Tablets 250 mg + 25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21324

Manufacturer usually replies in nan days

cycloserine

Capsules 125 mg, 250 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21324

Manufacturer usually replies in nan days

Markets of interest

As a broad spectrum antibiotic Cycloserine, is prescribed as a second line agent to treat drug resistant tuberculosis, bladder or kidney infections. The medication is always used in combination with other antituberculosis agents. The substance interferes with bacterial cell wall synthesis by competitively inhibiting two enzymes responsible for peptidoglycan formation which is necessary for bacterial cell wall synthesis. The medication is available for sale in the form of capsules and tablets at concentration 250mg in one unit, from manufacturers in various countries including Y. The drug is provided by a wide range of cycloserine suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading cycloserine manufacturers and distributors are based in India and China. Licensing and brand names Cycloserine was approved for use in the United States in 1964 by FDA. The drug later was replaced by more modern antituberculosis agents except in instances of multidrug resistance or of intolerance to the more potent agents. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under the trade names including Neosporin Wound Cleanser, Merthiolate, CureChrome, Eudermis. One of the more popular branded versions of cycloserine is manufactured and supplied by the Chinese pharmaceutical company, JINLAN Pharm-Drugs Technology Co., Ltd. Other manufacturing companies and distributors from the European Union, India, Ukraine, Argentina, have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with cycloserine as an active ingredient.

Target supply price

The wholesale acquisition cost of medication in the U.S. for cycloserine oral capsule 250 mg is around $1,590 for a supply of 30 capsules. The retail price in the EU of this drug depending on the pack size ranges between 20 EUR and 22 EUR. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the cycloserine manufacturers and suppliers that you are looking for. You can also find the dossier status of cycloserine and the GMP approvals of the different variants of the medication. The product description of all cycloserine suppliers contain essential information about the medication you order including clinical data, stability zones, and a list of countries where cycloserine is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms.Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified cycloserine suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.